Package 25021-239-26

Brand: gemcitabine

Generic: gemcitabine
NDC Package

Package Facts

Identity

Package NDC 25021-239-26
Digits Only 2502123926
Product NDC 25021-239
Product ID 25021-239_adf9b715-8cef-4a0d-ba30-d948b2b04272
Description

1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2019-01-15
Brand gemcitabine
Generic gemcitabine
Sample Package No

Linked Drug Pages (1)

Gemcitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "adf9b715-8cef-4a0d-ba30-d948b2b04272", "openfda": {"unii": ["U347PV74IL"], "rxcui": ["1720960", "1720975", "1720977"], "spl_set_id": ["22af3507-4b4f-4cad-9d61-89ffc4aabbc7"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-239-05)  / 5.26 mL in 1 VIAL", "package_ndc": "25021-239-05", "marketing_start_date": "20190115"}, {"sample": false, "description": "1 VIAL in 1 CARTON (25021-239-26)  / 26.3 mL in 1 VIAL", "package_ndc": "25021-239-26", "marketing_start_date": "20190115"}, {"sample": false, "description": "1 VIAL in 1 CARTON (25021-239-52)  / 52.6 mL in 1 VIAL", "package_ndc": "25021-239-52", "marketing_start_date": "20190115"}], "brand_name": "Gemcitabine", "product_id": "25021-239_adf9b715-8cef-4a0d-ba30-d948b2b04272", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-239", "generic_name": "gemcitabine", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gemcitabine", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "38 mg/mL"}], "application_number": "ANDA209077", "marketing_category": "ANDA", "marketing_start_date": "20190115", "listing_expiration_date": "20261231"}